<DOC>
	<DOCNO>NCT01269905</DOCNO>
	<brief_summary>The optimal valve substitute patient 60-70 year controversial . We compare anticoagulation-related adverse event ( ARAE ) patient receive mechanical heart valve replacement ( MHVR ) INR self-management vs. stentless bioprosthesis , ass whether risk structural valve deterioration ( SVD ) still out-weighted benefit require permanent anticoagulation .</brief_summary>
	<brief_title>Choice Valve Substitute Era Oral Anticoagulation Self-Management</brief_title>
	<detailed_description />
	<criteria>heart valve replacement CABG Afib</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2005</verification_date>
</DOC>